Literature DB >> 8333305

Intraventricular haemorrhage caused by aneurysms and angiomas.

E Donauer1, J Reif, B al-Khalaf, E F Mengedoht, C Faubert.   

Abstract

More than 200 intraventricular haematomas (IVH) have been treated in the Homburg Neurosurgical University Clinic since computed tomography was available and facilitated the diagnosis. Among 200 consecutive cases, which are analysed and presented in this publication, there were 71 patients with subarachnoid haemorrhage (SAH)--58 of whom with angiographically and/or pathologically verified aneurysms--, and 21 cases with intraventricular angiomas. IVH without concomitant intracerebral haematoma (ICH) and without evidence of SAH is highly suggestive of intraventricular angioma. In our experience panangiography [if available digital subtraction angiography (DAS)] should be done as soon as possible in all cases of IVH. It is a precondition for early diagnosis and operative elimination of the source of bleeding, because the retrospective analysis of our material shows that rebleeding is by far the highest single risk factor in cases with IVH caused by aneurysms or angiomas. We therefore recommend early microsurgical occlusion of the aneurysms and exstirpation or intravascular embolisation of the angioma. The best survival rate (76%) was achieved in IVH cases caused by angiomas. In aneurysms with IVH the survival rate was 35%, in IVH caused by other diseases 37%. The worst prognosis occurs in SAH with IVH without proven aneurysm or angioma. The survival rate of this group was only 8%.

Entities:  

Mesh:

Year:  1993        PMID: 8333305     DOI: 10.1007/bf01446982

Source DB:  PubMed          Journal:  Acta Neurochir (Wien)        ISSN: 0001-6268            Impact factor:   2.216


  16 in total

1.  Intraventricular hemorrhage in adults.

Authors:  J R Little; G A Blomquist; R Ethier
Journal:  Surg Neurol       Date:  1977-09

2.  Management morbidity and mortality of poor-grade aneurysm patients.

Authors:  J E Bailes; R F Spetzler; M N Hadley; H Z Baldwin
Journal:  J Neurosurg       Date:  1990-04       Impact factor: 5.115

3.  The surgical treatment of intracerebral and intraventricular haematomas.

Authors:  H W Pia
Journal:  Acta Neurochir (Wien)       Date:  1972       Impact factor: 2.216

4.  Surgical risk as related to time of intervention in the repair of intracranial aneurysms.

Authors:  W E Hunt; R M Hess
Journal:  J Neurosurg       Date:  1968-01       Impact factor: 5.115

5.  Cerebral arteriovenous malformations: considerations for and experience with surgical treatment in 166 cases.

Authors:  C G Drake
Journal:  Clin Neurosurg       Date:  1979

6.  [Clinical aspects and prognosis of intraventricular hemorrhage with cerebrovascular disease. CT findings and etiological analysis].

Authors:  Y Ikeda; S Nakazawa; H Higuchi; K Ueda; K Yajima
Journal:  Neurol Med Chir (Tokyo)       Date:  1982-10       Impact factor: 1.742

7.  Microsurgical excision of paraventricular arteriovenous malformations.

Authors:  H S U
Journal:  Neurosurgery       Date:  1985-03       Impact factor: 4.654

8.  Does the timing of aneurysm surgery neglect the real problems of subarachnoid haemorrhage?

Authors:  N Freckmann; M Noll; D Winkler; G Nowak; H Rehn; M Neuss; H D Herrmann
Journal:  Acta Neurochir (Wien)       Date:  1987       Impact factor: 2.216

9.  Prognostic factors in intraparenchymatous hematoma with ventricular hemorrhage.

Authors:  J Ruscalleda; A Peiró
Journal:  Neuroradiology       Date:  1986       Impact factor: 2.804

10.  The impact of rebleeding on the life time probabilities of different outcomes in patients with ruptured intracranial aneurysms. A theoretical evaluation.

Authors:  V Eskesen; J Rosenørn; K Schmidt
Journal:  Acta Neurochir (Wien)       Date:  1988       Impact factor: 2.216

View more
  7 in total

1.  Mental Dullness after thrombolytic therapy.

Authors:  K S Woo; H C Chan; W S Poon
Journal:  Postgrad Med J       Date:  1997-06       Impact factor: 2.401

2.  Intraventricular hemorrhage secondary to intranidal aneurysm rupture-successful management by arteriovenous malformation embolization followed by intraventricular tissue plasminogen activator: case report.

Authors:  Glen A Pollock; Ali Shaibani; Issam Awad; H Hunt Batjer; Bernard R Bendok
Journal:  Neurosurgery       Date:  2011-02       Impact factor: 4.654

3.  Hydrocephalus after intraventricular hemorrhage: the role of thrombin.

Authors:  Feng Gao; Fuyi Liu; Zhi Chen; Ya Hua; Richard F Keep; Guohua Xi
Journal:  J Cereb Blood Flow Metab       Date:  2013-12-11       Impact factor: 6.200

4.  Predisposing factors related to shunt-dependent chronic hydrocephalus after aneurysmal subarachnoid hemorrhage.

Authors:  Jae-Hyun Kwon; Soon-Ki Sung; Young-Jin Song; Hyu-Jin Choi; Jae-Taeck Huh; Hyung-Dong Kim
Journal:  J Korean Neurosurg Soc       Date:  2008-04-20

5.  Intraventricular recombinant tissue plasminogen activator for lysis of intraventricular haemorrhage.

Authors:  V Rohde; C Schaller; W E Hassler
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-04       Impact factor: 10.154

6.  Comparison of Incidence and Risk Factors for Shunt-dependent Hydrocephalus in Aneurysmal Subarachnoid Hemorrhage Patients.

Authors:  In-Seok Bae; Hyeong-Joong Yi; Kyu-Sun Choi; Hyoung-Joon Chun
Journal:  J Cerebrovasc Endovasc Neurosurg       Date:  2014-06-30

7.  Clinical features and prognostic factors in patients with intraventricular hemorrhage caused by ruptured arteriovenous malformations.

Authors:  Zengpanpan Ye; Xiaolin Ai; Xin Hu; Fang Fang; Chao You
Journal:  Medicine (Baltimore)       Date:  2017-11       Impact factor: 1.817

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.